Financial News

Veracyte Inc (NQ: VCYT )

38.67 -0.27 (-0.70%)

Streaming Delayed Price Updated: 10:50 AM EST, Nov 22, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Veracyte Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings

May 10, 2021

Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:

Via Benzinga

Veracyte, Inc. Announces CEO Succession Plan

May 10, 2021

From Veracyte, Inc.

Via Business Wire

Earnings Scheduled For May 10, 2021

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Veracyte Announces First Quarter 2021 Financial Results

May 10, 2021

From Veracyte, Inc.

Via Business Wire

Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com

May 09, 2021

Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...

Via Benzinga

Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress

May 04, 2021

From Veracyte, Inc.

Via Business Wire

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Exposures COVID-19 Product Safety

Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know

May 07, 2021

Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...

Via Benzinga

Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO

April 29, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis

April 27, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021

April 20, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference

April 19, 2021

From Veracyte

Via Business Wire

54 Biggest Movers From Friday

April 19, 2021

Gainers Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares surged 73.9% to close at $31.30 on Friday after the company priced its IPO at $18 per share. General Finance...

Via Benzinga

Topics Initial Public Offering

Exposures Securities Market

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results

April 15, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test

April 14, 2021

From Veracyte

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Veracyte Inc (NQ: VCYT )

All News about Veracyte Inc

Popular Pages